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Research Paper 
Peroxynitrous acid (ONOOH) modifies the structure of anastellin and 
influences its capacity to polymerize fibronectin 
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A B S T R A C T   
Anastellin (AN), a fragment of the first type III module in fibronectin (FN), initiates formation of super-
fibronectin, a polymer which resembles the native cell-derived fibrillar FN found in the extracellular matrix of 
many tissues, but which displays remarkably different functional properties. Here we demonstrate that exposure 
of AN to the biologically-important inflammatory oxidant, peroxynitrous acid (ONOOH), either as a bolus or 
formed at low levels in a time-dependent manner from SIN-1, impairs the capability of AN to polymerize FN. In 
contrast, exposure of FN to ONOOH does not seem to affect superfibronectin formation to the same extent. This 
oxidant-induced loss-of-function in AN occurs in a dose-dependent manner, and correlates with structural per-
turbations, loss of the amino acid tyrosine and tryptophan, and dose-dependent formation of modified amino 
acid side-chains (3-nitrotyrosine, di-tyrosine and 6-nitrotryptophan). Reagent ONOOH also induces formation of 
oligomeric species which decrease in the presence of bicarbonate, whereas SIN-1 mainly generates dimers. 
Modifications were detected at sub-stoichiometric (0.1-fold), or greater, molar excesses of oxidant compared to 
AN. These species have been localized to specific sites by peptide mass mapping. With high levels of oxidant 
(>100 times molar excess), ONOOH also induces unfolding of the beta-sheet structure of AN, thermal destabi-
lization, and formation of high molecular mass aggregates. These results have important implications for the 
understanding of FN fibrillogenesis in vivo, and indicates that AN is highly sensitive to pathophysiological levels 
of oxidants such as ONOOH.   
1. Introduction 
Fibronectin (FN) is a dimeric multimodular glycoprotein present in 
vivo as two different isoforms: a soluble form in blood plasma, and as an 
insoluble form generated by endothelial, epithelial and fibroblast cells, 
that contains additional modules. The latter forms fibrils in the extra-
cellular matrix (ECM)   the scaffold that provides strength and form to 
most biological tissues. Each monomer is composed of domains of 
repeating type I (FNI), II (FNII), and III (FNIII) modules which provide 
different functionalities and binding sites for a variety of bio-
macromolecules, including integrins, collagen, heparin, and 
proteoglycans [1,2]. The circulating soluble form produced by hepato-
cytes is recruited to sites of injury where it is cross-linked with fibrin-
ogen to form a temporary scaffold for attachment of cells involved in 
repair and wound healing [3]. The fibrillar form of FN derived from cells 
involved in matrix synthesis such as fibroblasts, endothelial cells and 
smooth muscle cells, plays an important role in cell adhesion and 
migration, and has a strong influence on tumor growth, angiogenesis 
and metastasis [4,5]. The process of FN fibrillogenesis in the ECM is not 
fully understood but strong evidence supports involvement of in-
teractions between FN and integrin receptors on the cell surface [6]. Cell 
contraction mediated by the cytoskeleton exerts a pulling force on FN 
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via integrin receptors which exposes cryptic sites that initiate fibrillation 
through interactions with proximal FN protomers [7]. Anastellin (AN), a 
small ~ 9 kDa fragment from the C-terminal part of the first type III 
module (FNIII1) in FN can initiate formation of so-called super-
fibronectin in vitro, a fibrillar form which resembles ECM FN at the 
microscopic level, but displays higher cell adhesiveness than regular 
ECM fibrils and suppresses cell migration [8]. AN lacks the two first 
β-strands present in FNIII1 and is believed to represent a partially 
unfolded intermediate with exposed hydrophobic patches that bind to 
interaction sites in transiently unfolded FN, thereby promoting poly-
merization [9–11]. AN can also bind to previously assembled FN in the 
ECM in vivo, and thereby modulate the structure of FN and the sur-
rounding ECM [12–14]. These events have been linked to perturbations 
in cell signaling pathways such as those involving p38, ERK, VEGF, and 
lysophospholipids [12,15–17]. In addition, AN and superfibronectin 
display anti-metastatic properties in mice injected with multiple human 
tumor cell types [18,19]. These functions however appear to be inde-
pendent of the fibrillation activity of AN since they are not perturbed in a 
mutant that lacks the ability to form superfibronectin [16,20]. 
Oxidants such as peroxynitrous acid (ONOOH) and hypochlorous 
acid (HOCl) are released into the ECM by activated leukocytes and 
macrophages during inflammation [21]. These oxidants are key com-
ponents of the innate immune response to invading pathogens, but 
excessive or unintended formation can also result in damage to host 
tissues and modify ECM components, including FN [22]. This has 
functional implications, as cells adhere to ONOOH-modified FN to a 
much lower extent than native FN, with this occurring in a 
dose-dependent manner with increasing ONOOH exposure [23]. 
ONOOH is formed at a diffusion-controlled rate from superoxide (O2
-.) 
generated by NADPH oxidases (and also other processes), and nitric 
oxide (NO.) produced by nitric oxide synthases [24]. ONOOH can either 
induce oxidation directly, or undergo secondary reactions to form other 
reactive species. Thus, ONOOH can decompose (to a limited extent) to 
the reactive radicals HO. and NO2
. , or react with CO2 to form perox-
ynitrosocarbonate (ONOOCO2
- ). The latter can, in turn decompose to 
NO2
. and CO3
-. [25]. Each of these species can induce damage to a greater 
or lesser extent. Tyrosine (Tyr) and tryptophan (Trp) residues are major 
targets of the radicals formed from ONOOH and ONOOCO2
- , resulting in 
the formation of 3-nitroTyr, 6-nitroTrp, and the cross-linked species 
di-tyrosine (di-Tyr) [26]. As AN contains several exposed aromatic res-
idues, and few alternative ONOOH-reactive species (e.g. no cysteine or 
methionine residues), we hypothesized that Tyr and Trp might be major 
targets in AN for ONOOH and ONOOCO2
- , and that this might modify AN 
structure and function, with downstream effects on FN polymerization. 
2. Materials and methods 
2.1. Materials 
All chemicals including lyophilized human plasma FN (#F1056) and 
anti-3-nitroTyr polyclonal antibody (pAb; #06-284) were from Sigma- 
Aldrich (St Louis, Missouri, USA) unless stated otherwise, and all solu-
tions were prepared with Milli-Q grade water (Millipore Advantage A10; 
Merck-Millipore, Billerica, MA, USA). Peroxynitrous acid (ONOOH) was 
synthesized in a two-phase system using isoamyl nitrite/hydrogen 
peroxide (H2O2), with unreacted H2O2 removed using manganese di-
oxide [27]. Stock solutions of ONOOH were stored at -80 C. Before use, 
the concentration of ONOOH (diluted in 0.1 M NaOH) was determined 
by UV–vis spectrophotometry (UV-2600, Shimadzu, Japan) at 302 nm 
(extinction coefficient 1670 M  1 cm  1) [28]. Isopentyl nitrite, 5-ami-
no-3-(4-morpholinyl)-1,2,3-oxadiazolium chloride (SIN-1 chloride), 
HEPES, NaCl, EDTA, glycerol, β-mercaptoethanol were purchased from 
VWR. Isopropyl-β-D-thiogalactoside was obtained from Biosynth AG 
(Staad, Switzerland). Decomposed oxidant solutions (indicated as 
dONOOH and dSIN-1) were prepared by incubating ONOOH/SIN-1 in 
100 mM sodium phosphate buffer (pH 7.4) at 37 C for 90 min. The 
anti-6-nitroTrp (clone 117C) and anti-di-Tyr (clone 1C3) monoclonal 
antibodies (mAb) were from the Japan Institute for the Control of Aging 
(Shizuoka, Japan). Horseradish peroxidase (HRP)-conjugated sheep 
anti-mouse secondary antibody and HRP-conjugated donkey anti-rabbit 
secondary antibody were purchased from VWR. Western lighting 
Plus-ECL Enhanced chemiluminescence substrate was from Perkin 
Elmer (USA). 
2.2. Production of recombinant anastellin 
Escherichia coli codon optimized human AN construct (DNA and 
encoded protein sequence are available in Supplementary data) was 
purchased from GenScript Biotech (Leiden, Netherlands). AN was cloned 
into the vector pET21a, containing a C-terminal hexahistidine tag 
(HisTag) for downstream affinity chromatography purification. The 
construct was transformed into the E. coli C43 (DE3) expression strain 
and cells were grown in Luria-Bertani media at 37 C until the OD600 
reached 0.6–0.8. Protein synthesis was induced with 1 mM isopropyl- 
β-D-thiogalactoside at 15 C for about 16 h. Cells were harvested by 
centrifugation at 8000g for 15 min, and resuspended at 5 mL g  1 wet 
cells in buffer containing 25 mM HEPES-NaOH, pH 7, 100 mM NaCl, 
0.25 mM EDTA, 20% v/v glycerol, 5 mM β  mercaptoethanol, one 
SIGMAFAST™ protease inhibitor tablet per 6 L culture, and then stored 
at -20 C. The thawed cells were passed through a cell disruptor (Con-
stant Systems Limited, Daventry, UK) twice at 25 kpsi, then cell debris 
were spun down at 20,000 g for 40 min, and 2 μg mL  1 DNase I and 1 
mM phenylmethanesulphonyl fluoride were added. The supernatant 
from 6 L culture was adjusted to 50 mM imidazole prior to loading on a 
5 mL HisTrap HP column (GE Healthcare Life Sciences, Uppsala, Swe-
den) equilibrated in buffer containing 25 mM HEPES-NaOH pH 7, 100 
mM NaCl, 0.25 mM EDTA, 20% v/v glycerol, 5 mM β  mercaptoethanol, 
using an Akta pure chromatographic system (GE Healthcare Life Sci-
ences), and eluted with the same buffer containing 500 mM imidazole. 
Some of the fractions following affinity chromatography purification 
contained a small amount of precipitate, which was removed by 
centrifugation at 4500 g for 5 min. Protein-containing fractions were 
pooled, concentrated to 5 mg mL  1 on Vivaspin concentrators (molec-
ular mass cut-off: 10 kDa; Sartorius, Gottingen, Germany) and loaded (in 
1 mL aliquots), in sequential runs, onto a 24 mL size-exclusion chro-
matography (SEC) Superdex 75 Increase 10/300 GL column (GE 
Healthcare Life Sciences) equilibrated with phosphate-buffered saline 
(PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 1.8 mM 
KH2PO4). The major A280 nm peak was collected, assessed for purity by 
SDS-PAGE, concentrated to 1 mg mL  1, and stored at -80 C. 
2.3. Preparation of modified anastellin and fibronectin 
AN (5 μM) was exposed to ONOOH (0–500 μM) or SIN-1 (0–100 μM) 
in 100 mM phosphate buffer (pH 7.4) for 30 min at 37 C, in the absence 
or presence of 25 mM sodium bicarbonate (NaHCO3), prior to analysis 
by SDS-PAGE, ELISA or mass spectrometry, as described below. For 
studies of superfibronectin (sFN) formation, AN (40 μM) and FN (0.4 mg 
mL  1; 1.4 μM) was incubated separately with different concentrations of 
ONOOH (0–8 mM) for 30 min at 21 C in 100 mM sodium phosphate 
buffer (pH 7.4). These conditions were also used for CD spectroscopy 
and analysis of AN aggregates outlined in sections 2.9  2.11 below. The 
samples were then buffer exchanged into 10 mM sodium phosphate 
buffer (pH 7.4) using spin filters (Amicon Ultra-0.5 Centrifugal Filter 
Unit, 3 kDa), with the protein concentration subsequently determined 
using the BCA assay. The protein samples were then diluted to the 
required concentration using 10 mM phosphate buffer (pH 7.4) and 
centrifuged at 20,000 g for 10 min at 4 C to remove any preformed 
aggregates. 
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2.4. Turbidity assay 
Turbidity measurements were performed with a Spectra Max® i3x 
microplate reader to study the effect of oxidation on the kinetics of sFN 
formation. Native or oxidized AN (40 μM) and FN (0.4 mg mL  1; 1.4 
μM), prepared as described in section 2.3, were mixed in a final volume 
of 100 μL in 10 mM sodium phosphate buffer, pH 7.4. The turbidity of 
the solution at 550 nm was then measured at 1 min intervals for a period 
of 40 min at 21 C. 
2.5. Sedimentation assay 
Native or oxidized AN (40 μM) and FN (1 μM), prepared as described 
in section 2.3, were mixed in a final volume of 20 μL in 10 mM sodium 
phosphate buffer (pH 7.4) containing 5 mM EDTA and incubated over-
night at 21 C. After incubation, the samples were centrifuged at 20,000 
g for 10 min at 4 C. The insoluble fibril pellets were then washed with 
20 μL 10 mM sodium phosphate buffer (pH 7.4). Some pellets of native 
AN and FN were subsequently incubated with different concentration of 
ONOOH (0–800 μM) in 20 μL for 30 min at 21 C in 100 mM sodium 
phosphate buffer (pH 7.4). All samples were analyzed by SDS-PAGE 
under reducing conditions as described below. 
2.6. SDS-PAGE, western blotting and ELISA 
SDS-PAGE was carried out on 1.5 mm NuPAGE NOVEXs 4–12% Bis- 
Tris Gels using NuPAGE MES SDS Running Buffer (20x stock) at 160 V 
for 1 h. Samples were incubated with NuPAGE LDS Sample Buffer with 
reducing agent according to the manufacturer’s instructions (Invi-
trogen). Protein loading per lane was 1.8–2 μg with Precision Plus 
Protein™ Kaleidoscope™ pre-stained protein standards (10–250 kDa) 
used as a reference. Following electrophoretic separation, proteins were 
visualized using Coomassie staining, or transferred to immunoblotting 
membranes using an iBlot transfer apparatus (Invitrogen). PVDF mem-
branes were then blocked with 1% (w/v) BSA in TBS with Tween 20 
(TBST) for 1 h, and then incubated with an anti-3-nitroTyr pAb (#06- 
284, 1:3000 dilution) in blocking solution overnight at 4 C. Membranes 
were rinsed three times for 10 min with TBST before incubation with an 
HRP-conjugated anti-rabbit IgG antibody (1:10000 dilution) for 1 h. 
Unbound antibody was removed by washing three times for 10 min with 
TBST, then immune complexes were detected using Western Lightning 
Plus ECL reagent. Images were acquired using a Sapphire Biomolecular 
Imager (Azure Biosystems). For ELISA, proteins were coated in high- 
binding 96-well plates (Greiner) at 4 C overnight with 50 μL per well. 
Unbounded proteins were then removed by washing twice with PBS (pH 
7.4), followed by blocking with 1% (w/v) BSA in PBS, and incubation 
with anti-6-nitroTrp mAb (clone 117C, 1:3000 dilution) or anti-diTyr 
mAb (clone 1C3, 1:3000 dilution) at 4 C overnight. Plates were 
rinsed twice with PBS and incubated with IgG secondary antibodies at 
21 C for 1 h. After three washes with PBS, the plates were incubated 
with ABTS solution (2,2‘-azinobis-3-ethylbenzothiazoline-6-sulfonic 
acid) and H2O2 (1000:1). Absorbance values were then determined at 
405 nm using a Spectra Max® i3x microplate reader. 
2.7. Mass spectrometry – amino acid analysis 
Amino acids released from AN by acid hydrolysis was analyzed by 
mass spectrometry essentially as previously described by Gamon et al. 
[29]. Briefly, protein samples (25 μg) were precipitated with trichloro-
acetic acid (w/v 8 %) and spiked with stable isotope-labelled amino acid 
standards before drying down using a centrifugal vacuum concentrator 
for 30 min at 30 C. The resulting pellet was hydrolyzed overnight in 4 M 
methanesulfonic acid with 0.2 % w/v tryptamine (50 μL) under vacuum 
at 110 C. Amino acids were partially purified by solid-phase extraction 
using 30 mg/1 mL mixed-mode strong cation exchange Strata X–C car-
tridges (Phenomenex). Eluted fractions were dried at 30 C under 
vacuum overnight, and then dissolved in 50 μL of 0.1 % formic acid. 
Analytes were quantified by ESI LC-MS in positive ion mode using a 
Bruker Impact HD II mass spectrometer. Samples were separated by 
gradient elution using an Imtakt Intrada Amino Acid 100  3.0 mm 
column with acetonitrile/formic acid (Solvent A; 100/0.3) and aceto-
nitrile/100 mM ammonium formate (Solvent B; 20/80). MS analyses 
and quantification was performed at the MS1 level. 
2.8. Peptide mapping mass spectrometry 
AN (25 μL, 5 μM) exposed to ONOOH as described above (section 
2.3) was mixed with 75 μL 8 M urea (in 100 mM Tris, pH 8.0) and 1 μL 
LysC (20 ng μL  1; Promega) then incubated at 21 C for 4 h. Subse-
quently 150 μL 100 mM Tris (pH 8.0), 500 μL H2O and 2 μL GluC (20 ng 
μL  1; Promega) were added, and the samples incubated overnight at 21 
C. Following solid phase extraction with Stage-tips, samples were 
analyzed on a Bruker Impact II ESI-QTOF (Bruker Daltonics) mass 
spectrometer in the positive ion mode with a Captivespray ion source 
connected on-line to a Dionex Ultimate 3000RSnano chromatography 
systems (Thermo Fisher Scientific). Peptides were separated on a Bruker 
Nanoelute column (15 cm  75 μm ID) with a solvent gradient over 65 
min, using acetonitrile with 0.1% formic acid at a flow rate of 300 nL 
min  1. The MS scan range was 150–1750 m/z with a cycle time of 2 s 
using MS and MS/MS sampling rates of 2 Hz. Database searches were 
performed with MaxQuant v1.6.1.0 using the following parameters: 
enzyme: GluC and LysC, with three missed cleavages; variable modifi-
cation: Tyr and Trp nitration (44.985 Da) and dinitration (89.97 Da); 
mass tolerance: 0.07 and 0.005 Da (first and main searches, respec-
tively); MS/MS mass tolerance: 40 ppm (first and main searches). 
2.9. Circular dichroism and thioflavin T binding 
Circular dichroism (CD) spectra were acquired on a Jasco-815 CD 
Spectrometer (Jasco Corporation, Japan) and used to monitor the sec-
ondary structure of AN [30]. Far-UV CD spectra of AN (prepared as 
described in section 2.3), and diluted to 0.10 mg mL  1 (10.6 μM) with 
10 mM phosphate buffer, pH 7.4, were recorded between 190–260 nm, 
in a 1-mm cell at 25 C, at 1 nm intervals with a 1 nm bandwidth, and a 
scan speed of 50 nm min  1, with six scans averaged for each spectrum. 
Reference samples without AN were measured correspondingly and 
subtracted using the Jasco Spectra Analysis software. The folding of AN 
was verified using the BeStSel online resource [31,32]. For CD mea-
surement as a function of temperature (20–90 C; 1 C min  1), the CD (at 
227 nm) was measured in a 10-mm temperature-controlled cell with a 2 
nm bandwidth. All CD data was converted to mean residue ellipticity 
using a molar concentration of 10.6 μM and 82 residues in AN 
(considering removal of the N-terminal methionine). The binding of 
Thioflavine T (ThT) was examined using protein solutions diluted to 10 
μM with 10 mM phosphate buffer, pH 7.4, in the presence of 25 μM ThT 
and 20 μM 3-[(3-cholamidopropyl)dimethyl-ammonio]-1-propane sul-
fonate (CHAPS) and then analyzed in a Spectra Max® i3x microplate 
reader with λex 440 nm (9 nm slit width) and emission recorded over the 
range 465–600 nm with a 15 nm slit width, with three spectra averaged. 
2.10. Small-angle X-ray scattering 
Small-angle X-ray scattering (SAXS) was carried out on oxidized AN 
samples (prepared as described in section 2.3), diluted to 100 μM with 
10 mM phosphate buffer, pH 7.4. Measurements were performed on an 
optimized NanoSTAR SAXS instrument [33] from Bruker AXS, equipped 
with scatterless pinholes [34] and a liquid Ga metal jet X-ray source 
(Excillum) [35], with an acquisition time of 30 min at 20 C. The data 
are presented as a function of the scattering vector q that is dependent on 
the scattering angle 2θ with q  4π/λ sinθ, where λ  1.34 Å. The 
SUPERSAXS program package (Oliveira, C.L.P. and Pedersen J.S, un-
published) was used for background subtraction and to convert data to 
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an absolute scale with water as a calibration standard. An indirect 
Fourier transformation was performed on the SAXS data [36,37] in 
order to obtain pair distance distribution functions (p(r)), with the latter 
being a histogram of distances between pairs of points, weighted by the 
excess scattering length density in these two points and thereby give 
structural information in real space. This can be used to determine the 
maximum diameter (Dmax) of the particles, as well as shape information. 
The radius of gyration, Rg, and forward scattering, I(0), was obtained for 
the complete unfolding series by performing Guinier fits. I(0) is 
approximately proportional to the protein concentration and mass and 
can therefore be used to calculate the protein aggregation state. Mo-
lecular mass (Mm) was determined according to equation (1): 
Mm I0⋅NA
c⋅Δρ2m
(1)  
where c is the sample concentration, Δρm  2.0  1010 cm g  1 is the 
scattering length density difference per unit mass and NA is Avogadro’s 
constant. The number of monomers in each sample was obtained using 
the theoretical molecular mass of AN (9.4 kDa). 
2.11. Thermophoresis 
AN prepared as described in section 2.3, was diluted to 1 mg mL  1 in 
10 mM phosphate buffer and placed in standard glass capillaries. The 
samples were then analyzed in a nano differential scanning fluorimetry 
(nanoDSF) device (Prometheus NT.48; NanoTemper Technologies, 
Munich, Germany). The sample temperature was varied in a linear 
manner from 20 to 95 C at a rate of 1 C min  1. After reaching the target 
temperature, the samples were cooled to 20 C at the same rate. During 
the temperature scan, the retroreflective intensity of the light beam 
passing through the capillary was measured to detect protein aggrega-
tion. The scattering signal was normalized to a baseline signal to obtain 
a value defined as “excess scattering”. 
2.12. Statistics 
Statistical analyses were performed using GraphPad Prism 
(version5.0, GraphPad Software, SanDiego, CA, USA) and IBM SPSS 
22.0. One-way ANOVA with post hoc analysis using Tukey’s multiple 
comparison test were performed on data from at least three independent 
experiments, with p < 0.05 considered significant, and the following 
annotation; *p < 0.05,**p < 0.01, ***p < 0.001, ****p < 0.0001. 
3. Results 
3.1. ONOOH and SIN-1 induce dose-dependent nitration of anastellin 
AN (5 μM) was treated with bolus ONOOH at 1:1–1:100 molar ratios 
(protein:ONOOH), then analyzed by SDS-PAGE to assess changes in 
protein structure. Native AN appeared as a single monomer band on 
Fig. 1. Structural modifications to AN induced by ONOOH and SIN-1. Purified AN (5 μM, in 100 mM phosphate buffer, pH 7.4) was exposed to ONOOH (A and B) or 
SIN-1 (C and D) at the molar ratios indicated for 30 min at 37 C, in either the absence (  ) or presence () of 25 mM sodium bicarbonate (NaHCO3) followed by 
separation by SDS-PAGE. Structural modifications were detected using either Coomassie staining (A and C), or by immunoblotting to PVDF membrane with sub-
sequent probing for the presence of 3-nitroTyr (B and D). Molecular mass markers are shown for reference. 
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Coomassie-stained gels (Fig. 1A). The apparent molecular mass of the 
protein does not accurately match the expected mass of the protein, 
probably as a result of the presence of the His-tag which has been re-
ported previously to result in abnormal gel migration [38]. The intensity 
of this band decreased with increasing oxidant exposure, with this being 
particularly noticeable at the highest oxidant doses (Fig. 1A); these 
changes were not observed with decomposed oxidant solutions. Corre-
sponding immunoblots using a 3-nitroTyr antibody demonstrated a 
dose-dependent increase in 3-nitroTyr formation on AN with equimolar 
or greater levels of ONOOH (Fig. 1B). An increase in material with 
molecular mass  20 kDa was detected concurrently, consistent with the 
formation of dimeric and oligomeric species. These bands were apparent 
with a ten-fold excess of ONOOH (50 μM), and increased with higher 
excesses of oxidant (Fig. 1B). In the presence of NaHCO3, the loss of the 
parent band was less pronounced, and lower levels of non-reducible high 
molecular mass species were detected. Less 3-nitroTyr was formed in the 
presence of NaHCO3, consistent with the formation of peroxyni-
trosocarbonate (ONOOCO2
- ) [39]. 
AN was also exposed to SIN-1 (5-amino-3-(4-morpholinyl)-1,2,3- 
oxadiazolium chloride, also known as linsidomine) a compound that 
releases O2
-. and NO. with a 1:1 stoichiometry when dissolved in aqueous 
solution, generating a steady flux of ONOO-/ONOOH [40]. Exposure to 
SIN-1 resulted in a dose-dependent increase in 3-nitroTyr formation and 
dimerization of AN, but in contrast to the bolus addition experiments 
with ONOOH, higher molecular mass species were not detected (Fig. 1C 
and D). The presence of NaHCO3 did not significantly affect the modi-
fication of AN induced by SIN-1 as observed by SDS-PAGE, although a 
slight increase in 3-nitroTyr was seen at low doses of SIN-1. 
Exposure of AN to increasing concentrations of ONOOH resulted in 
increased formation of di-Tyr and 6-nitroTrp, as detected by ELISA 
(Fig. 2). The maximum yield of di-Tyr was obtained with moderate ex-
cesses of oxidant; higher oxidant levels resulted in a reduced yield, 
possibly due to further reactions of this product (e.g. tri-tyrosine for-
mation) (Fig. 2A). The formation of 6-nitroTrp in AN occurred in a dose- 
dependent manner with significantly elevated levels observed with 500 
μM ONOOH (100-fold molar excess; Fig. 2B). 
The concentrations of 3-nitroTyr, di-Tyr, and 6-nitroTrp, together 
with the corresponding parent amino acids Tyr and Trp, in AN exposed 
to ONOOH were evaluated by quantitative LC-MS following acid hy-
drolysis, and separation of released amino acids by liquid chromatog-
raphy, as described in the Materials and methods. As reported previously 
[29], the parent amino acids were lost in a ONOOH dose-dependent 
manner (Fig. 3D and E), with this being matched by an corresponding 
increase in the yield of the modified species, particularly at low oxidant 
doses (Fig. 3A  C). With higher oxidant doses a plateau and subsequent 
decrease in the yield of di-Tyr were observed as seen in the ELISA ex-
periments. The overall pattern of modified products observed by mass 
spectrometry and ELISA were however similar. The specific sites of 
modification on AN were examined by LC-MS/MS peptide mass map-
ping, after proteolytic digestion. In agreement with the results presented 
in Fig. 1  3, a dose-dependent increase in the number of identified 
nitrated peptides was observed, with each of the four Tyr and two Trp 
residues in AN detected as modified species (Table 1). 
3.2. Modified anastellin displays impaired capacity to polymerize 
fibronectin 
When AN is mixed with FN, insoluble fibrils (superfibronectin, sFN) 
are formed [8]. The kinetics of sFN formation with native or 
ONOOH  modified AN was monitored as turbidity at 550 nm after 
mixing AN with FN. At moderate ONOOH concentrations ( 80 μM) the 
time course of sFN formation with modified AN was similar to the native 
protein, with an initial rapid increase in turbidity, followed by a slower 
phase (Fig. 4A). However, at the highest concentration of ONOOH (800 
μM) there was a lag phase before the increase in turbidity was detected, 
consistent with a reduced ability of AN to polymerize FN (Fig. 4A). 
Conversely, the kinetic profiles of sFN formation using native AN mixed 
with either native or ONOOH-modified FN were similar, suggesting that 
modification of FN under these conditions does not influence the poly-
merization process (Fig. 4B). 
sFN formation was also monitored using a sedimentation assay 
where insoluble fibrils formed on incubation of AN with FN, were iso-
lated by centrifugation, and analyzed by SDS-PAGE. In agreement with 
the turbidity data (Fig. 4), high yields of sFN were obtained after mixing 
AN with FN, whereas only low levels of aggregates where observed with 
either protein in isolation (data not shown). The yield of sFN was 
quantified by comparing the intensities of the AN and FN monomer 
bands in insoluble sFN pellets formed after incubation of native FN with 
ONOOH-treated AN (Fig. 5A). For native FN incubated with ONOOH- 
treated AN, a dose-dependent decrease in the intensity of the AN 
monomer band was detected. This decrease might arise (at least 
partially) from ONOOH-induced oligomer formation from AN (Fig. 1). In 
contrast, the decreased intensity of the monomer band for FN (which 
had not been exposed to oxidant) in Fig. 5A is most likely due to reduced 
yields of sFN from ONOOH-modified AN, in accordance with the 
turbidity data (Fig. 4). Corresponding immunoblots provided evidence 
for a dose-dependent increase in 3-nitroTyr and oligomeric species in 
sFN formed with AN exposed to equimolar or greater levels of ONOOH, 
suggesting that modified AN can be incorporated into sFN (Fig. 5D). The 
intensity of the 3-nitroTyr signal decreased at higher levels of oxidant, 
which may be due to a decrease in the incorporation of modified AN into 
sFN, and/or a reduction of total yield of sFN. 
Sedimentation assays were also performed with native AN and 
ONOOH-treated FN (Fig. 5B). The observed dose-dependent decrease in 
intensity of the FN monomer band in sFN from ONOOH-treated samples 
is likely to be due to the formation of higher molecular mass aggregates, 
as observed previously for FN exposed to ONOOH [41]. No significant 
decrease was however observed for the AN monomer band in sFN, 
formed after treatment of FN with ONOOH (Fig. 5B). These results 
suggest that oxidant exposure of FN does not influence the yield of sFN, 
under the conditions tested, in agreement with the turbidity data 
(Fig. 4). 3-NitroTyr and oligomeric species were detected on FN in sFN, 
with the level of these increasing at higher oxidant doses, suggesting 
that modified FN is incorporated into sFN (Fig. 5E). Incubation of 
Fig. 2. Detection of di-Tyr (A) and 6-nitroTrp (B) on 
AN arising from exposure to ONOOH, as determined 
by ELISA. Purified AN (5 μM, in 100 mM phosphate 
buffer, pH 7.4) was exposed to ONOOH at the molar 
ratios indicated for 30 min at 21 C. Modifications 
were quantified with ELISA using specific antibodies 
against di-Tyr (mAb clone 1C3) and 6-nitroTrp (mAb 
clone 117C). Statistical differences relative to control 
were analyzed by one-way ANOVA with Tukey’s 
post-hoc test. Data are presented as means  SD from 
three experiments, and are expressed as % values 
relative to those detected in the control without 
added ONOOH.   
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preformed sFN with ONOOH decreased the intensity of the monomer 
band of both AN and FN in a dose-dependent manner (Fig. 5C). 3-Nitro-
Tyr was however detected primarily on FN, when compared to AN 
(Fig. 5F). This is not unexpected given that FN is a much larger protein 
and has a greater number of ONOOH reactive side-chains. Thus FN 
contains 100 Tyr and 39 Trp residues, respectively (based on the ca-
nonical sequence of human FN, Uniprot ID P02751), whereas AN con-
tains 4 Tyr and 2 Trp. Assuming a molar 4:1 AN:FN ratio in sFN as 
reported previously [11], this corresponds to an approximate 6- and 
5-fold higher concentration of Tyr and Trp in FN, when compared with 
AN, under these conditions. 
3.3. ONOOH induces aggregation of anastellin 
As the data reported above indicate formation of AN oligomers on 
oxidant exposure, the size and shape of these species were examined in 
solution using SAXS. Fig. 6A shows normalized scattering data for AN 
solutions that had been exposed to different concentrations of ONOOH. 
These data indicate that there are no significant differences amongst the 
samples treated with low micromolar concentrations of ONOOH. How-
ever, for samples exposed to higher concentrations of ONOOH ( 800 
μM), the intensity increased both in the low and the high q regions, 
indicating that the size of the AN species is increased. Fig. 6B shows the 
distance distribution function (p(r)) of the AN samples, which can be 
Fig. 3. Quantification of the modification products di-Tyr (A), 6-nitroTrp (B), 3-nitroTyr (C), and the parent amino acids Tyr (D), and Trp (E) in AN (5 μM) exposed 
to ONOOH (0–500 μM) by LC-MS analysis of free amino acids and product species after protein digestion using methanesulfonic acid (see Materials and methods). 
Statistical differences relative to the control without added ONOOH was determined by one-way ANOVA using Tukey’s post-hoc test. Fig. 3D and E are reprinted from 
Ref. [17] with permission from Elsevier. 
Table 1 
Nitrated peptides from AN (5 μM) exposed to different concentrations of ONOOH detected by mass spectrometry following proteolytic digestion with LysC and GluC.  
Sequence¤ Nitrated residues ONOOH 
0 μM 
ONOOH 
0.5 μM 
ONOOH 
5 μM 
ONOOH 
50 μM 
ONOOH 
500 μM 
YILRWRPK Tyr15     
YILRWRPK Tyr15, Trp19     
YILRWRPK Trp19   
NSVGRWKEATIPGHLNSYTIK Trp28    
NSVGRWKEATIPGHLNSYTIK Trp28, Tyr40     
NSVGRWKEATIPGHLNSYTIK Trp28, Tyr40     
NSVGRWKEATIPGHLNSYTIK Tyr40   
EATIPGHLNSYTIK Tyr40     
ATIPGHLNSYTIK Tyr40     
GLKPGVVYE Tyr51     
GLKPGVVYE Tyr51     
GQLISIQQYGHQE Tyr61     
GQLISIQQYGHQE Tyr61     
¤  3-nitroTyr/6-nitroTrp residues are highlighted in bold. Residues modified by dinitration are underlined. 
  detected in 1 replicate. 
  detected in 2 replicates. 
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used to determine the average molecular mass (Mm) and radius of gy-
ration (Rg) of the particles. Based on these data, the Mm of native AN is 
predicted to be 12 kDa, about 1.3 times higher than the theoretical Mm 
of AN monomers (9.4 kDa), and consistent with the presence of mainly 
monomeric and dimeric species. Treatment of 40 μM AN with low 
micromolar concentrations of ONOOH, gave only modest increases in 
Mm (Table 2), whereas with 800 μM and 8 mM ONOOH, the average 
Mm for soluble AN species was 26.7 and 104.8 kDa, respectively, indi-
cating the formation of large oligomers and aggregates; this is consistent 
with the SDS-PAGE and immunoblot data (Fig. 1). The Rg determined for 
native AN (approximately 1.9 nm) did not increase significantly with 
low micromolar ONOOH (Table 2), but this increased to 2.4 and 11.5 nm 
Fig. 4. Effect of ONOOH on kinetics of sFN aggregation. FN (1.4 μM) and AN (40 μM) were mixed in 10 mM phosphate buffer pH 7.4, with AN (A) or FN (B) exposed 
to the indicated concentrations of ONOOH for 30 min prior to buffer exchange into 10 mM phosphate buffer and mixing. The turbidity of the solution was then 
measured at 550 nm over 40 min at 21 C. 10 mM phosphate buffer was used as control. 
Fig. 5. Sedimentation assay of sFN formation from: native FN mixed with ONOOH-exposed AN (A, D); native AN mixed with ONOOH-exposed FN (B, E), and native 
FN and AN where the insoluble sFN pellet is exposed to ONOOH (C, F). AN and FN was incubated overnight at 21 C, followed by centrifugation and washed pellets 
with insoluble fibrils were separated by SDS-PAGE under reducing conditions. The intensities of the Coomassie-stained monomer bands (indicated by arrows in the 
panels) were determined by image analysis, with these data presented below each gel in panels A–C. Data are presented as means  SD from three experiments, and 
are expressed as a ratio relative to band intensity for the respective control data. Statistical differences relative to control without added ONOOH were assessed by 
one-way ANOVA with Tukey’s post-hoc test. Panels D–E display the corresponding immunoblots probed for the presence of 3-nitroTyr. 
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with 800 μM and 8 mM ONOOH, respectively, in agreement with the 
Mm data (Table 2). 
AN aggregation was also studied by measuring light scattering in a 
nanoDSF device coupled with thermal denaturation. In agreement with 
the SAXS data, a significant increase in light scattering was detected for 
the samples treated with ONOOH, consistent with a dose-dependent 
increase in aggregate formation (Fig. 6C). A further increase in light 
scattering above 80 C was observed for AN treated with 800 μM 
ONOOH. 
3.4. Modified anastellin displays decreased thermal stability 
The data reported above indicate that major structural perturbations 
occur on AN with extensive modification by ONOOH. The secondary 
structure of the protein was therefore investigated by far-UV CD spec-
troscopy. In agreement with previous observations [42] native AN dis-
plays a spectrum with a maximum at 198 nm and minimum at 228 nm 
(Fig. 7A), characteristic of the beta-sheet sandwich structures of FNIII 
modules. The observed CD is consistent with solution NMR data and 
indicate approximately 30% anti-parallel beta-sheets, 10% turns and 
60% unordered structural elements, when analyzed with the BeStSel 
algorithm [31,32,42]. These spectral features were retained when AN 
(40 μM) was treated with low or moderate levels of ONOOH, whereas 
treatment with 4–8 mM ONOOH (100 or 200-fold molar excesses) gave 
rise to features consistent with a largely disordered conformation, and 
minima at about 202 nm. This loss of folding after ONOOH treatment 
could be caused by a disruption of the hydrophobic core as two of the 
Tyr residues and both the Trp residues are proximal to the beta-sheet 
content of AN. The impact of ONOOH on thermal stability of AN was 
also monitored by CD. As the sample temperature was increased, the CD 
signal of AN at 227 nm decreased, passing through a thermal transition 
interval leading to conversion to a random coil structure (Fig. 7B). It has 
previously been reported that aromatic residues may influence CD sig-
nals in the 220–230 nm region [43]. However, at 227 nm the main 
contribution to the CD appears to come from the amide backbone 
transitions, as determined by BeStSel analysis [31,32] (see Materials and 
Methods) demonstrating that it is not necessary to take aromatic con-
tributions into account when analyzing the far-UV CD spectrum. The 
changes in CD with temperature reflect both changes in protein folding 
as well as effects of a linear temperature-dependence of the CD of a given 
fold [44]. Untreated AN exhibited a sharp thermal transition with a Tm 
Fig. 6. Aggregation of AN (40 μM) treated with different concentrations of ONOOH (0.8 μM  8 mM) for 30 min at 20 C, analyzed by: (A, B) SAXS, and (C) nanoDSF 
coupled with thermal denaturation from 20 to 95 C. (A) Variation of the scattered intensity I(q) versus the momentum transfer q  4π/λ sinθ. (B) The pair distance 
distribution functions (p(r)) was obtained from the indirect Fourier transformation of the intensities (see main text and Materials and methods). 
Table 2 
Determination of molecular mass (Mm) and gyration radius (Rg) for AN (40 μM) 
exposed to ONOOH by SAXS analysis. Physical parameters are determined from 
pair distance distribution functions (p(r)). The radius of gyration, Rg, and for-
ward scattering, I(0), was obtained for the complete unfolding series by per-
forming Guinier fits. The average number of monomers in each species was 
estimated based on the theoretical molecular mass for AN (9.4 kDa).   
Concentration 
(mg ml-1) 
I(0) 
(cm-1) 
Mm 
(kDa) 
Number of 
monomers 
Rg 
(nm) 
ONOOH 0 
μM 
0.925 0.007 12.0 
0.1 
~1.3 1.9 
0.1 
ONOOH 
0.8 μM 
0.74 0.006 11.8 
0.1 
~1.3 1.9 
0.1 
ONOOH 8 
μM 
0.925 0.009 13.9 
0.1 
~1.5 2.0 
0.1 
ONOOH 
80 μM 
0.74 0.008 16.5 
0.2 
~1.8 2.0 
0.1 
ONOOH 
800 μM 
0.925 0.016 26.7 
0.3 
~2.8 2.4 
0.1 
ONOOH 
8000 μM 
0.925 0.064 104.8 
 1.5 
~11.2 11.5 
 0.1  
Fig. 7. AN (40 μM) was treated with different concentrations of ONOOH (0.8 μM  8 mM) for 30 min at 20 C, then analyzed using far-UV CD spectroscopy. (A) CD 
spectra over the wavelength range 190–260 nm. (B, C) Profiles of thermal denaturation (B) and refolding (C) were detected by far-UV CD spectra at 227 nm in a 10- 
mm cell with the temperature increased at a rate of 1 C min  1 (B), and then subsequently decreased (C). 
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of ~65 C. When the sample was cooled down, the CD gradually 
increased without abrupt changes, consistent with refolding and 
reversible thermal denaturation of AN (Fig. 7C), in agreement with 
previous data from FNIII1 modules [45]. After treatment with a 20-fold 
molar excess of ONOOH (800 μM), the thermal stability of AN was 
altered as indicated by a much broader thermal transition and a slightly 
decreased Tm. With higher ONOOH concentrations the existence of a 
largely disordered conformation at room temperature prevented esti-
mation of Tm values. 
The benzothiazole dye ThT, which displays enhanced fluorescence 
when it binds to beta sheet-rich structures in amyloids, is widely used as 
a probe for protein unfolding and aggregation [46–48]. Native AN 
showed a high fluorescence emission intensity at 495 nm consistent with 
ThT binding, and the presence of hydrophobic patches and a beta-sheet 
structure on the protein surface (Fig. 8). The intensity of this fluores-
cence decreased upon ONOOH exposure in a dose-dependent manner, 
consistent with the loss of these structural elements. This may also be 
due to the conversion of the Tyr and Trp residues to more hydrophilic or 
charged products (see Discussion). Furthermore, this behavior suggests 
that the aggregates formed at high ONOOH concentrations have 
non-amyloid structures. 
4. Discussion 
This study demonstrates that ONOOH exposure impairs the ability of 
AN to initiate formation of sFN fibrils. This loss-of-function is associated 
with dramatic changes to the structure of AN with the formation of 
oligomers and aggregates. Significant levels of 3-nitroTyr and 6-nitroTrp 
were generated from Tyr and Trp residues, and the sites of these specific 
modifications have been identified. These data are consistent with pre-
vious reports demonstrating significant ONOOH-mediated damage at 
these side-chains [49]. Formation of di-Tyr cross-links was also detected 
although a decrease in the formation of these cross-links were observed 
at the highest ONOOH concentrations examined. This decrease in 
detected di-Tyr, may possibly be due to extensive aggregation and 
protein precipitation, which in the case of ELISA-based analyses may 
prevent access of the antibody to particular sites, or may be as a result of 
further oxidation (e.g. to tri-tyrosine). Consistent with the formation of 
di-Tyr, an increased detection of species with apparent molecular mass 
of approximately 20 kDa, and also higher mass species, were detected 
with ONOOH concentrations >50 μM, presumably corresponding to 
cross-linked dimers and higher oligomers of AN. Cys, cystine and Met 
residues are known to be major protein targets for ONOOH (with this 
occurring via both one- and two-electron oxidation reactions) [25]. 
However, these residues are absent in AN, and therefore Tyr and Trp 
residues are likely to be the major sites of modification with these re-
actions occurring via radical-mediated reactions. Consistent with this 
hypothesis, high levels of 3-nitroTyr were detected on the monomer, 
dimeric and oligomeric AN species. Evidence has also been obtained for 
the formation of significant concentrations of 6-nitroTrp from Trp resi-
dues. The formation of 3-nitroTyr and di-Tyr may reflect two alternative 
pathways for Tyr-derived phenoxyl radicals (TyrO.) formed on AN by 
HO and NO2 arising from decay of ONOOH, with the TyrO
. either 
undergoing dimerization to give di-Tyr, or further reaction with NO2
. to 
give 3-nitroTyr. Similar reactions involving Trp-derived indolyl radicals 
(TrpN.) are believed to be responsible for the formation of 6-nitroTrp, 
via reaction of TrpN. with NO2. Formation of the dimeric species, 
di-Trp, and also crossed-dimers (i.e. Trp-Tyr) may also occur; such 
species have been detected in other systems [50,51], and may also be 
formed with AN. 
The presence of HCO3
- decreased the observed extent of damage 
induced by bolus addition of ONOOH to AN solutions, in agreement with 
previous work on other ECM proteins such as laminin and FN [22,41, 
52]. ONOO- reacts with CO2/HCO3
- to form peroxynitrosocarbonate 
(ONOOCO2
- ) [53–55], which decomposes to form NO2and CO3-., so one 
potential explanation for this protection is the difference in reactivity of 
HO and CO3
-., as the latter is less reactive than the former [56,57]. In 
contrast, HCO3
- did not appear to have a protective effect toward 
modification of AN induced by treatment with SIN-1, which has been 
reported to form low fluxes of ONOOH in a sustained manner [40,58]. 
On the contrary, a slight increase in 3-nitroTyr formation was detected 
in the presence of HCO3
- at low concentrations of SIN-1. It is therefore 
postulated that the influence of HCO3
- on the reactivity of SIN-1 derived 
species towards AN is related to the overall flux of radicals (e.g. the 
kinetics of radical formation from ONOOCO2
- and ONOOH, and possible 
modulation of SIN-1 decomposition by HCO3
- ), and/or the occurrence of 
alternative reactions of the initial radicals formed from SIN-1 (O2
-. and 
NO.). 
ONOOH has been shown to induce changes in the secondary, ter-
tiary, and quaternary structure of many proteins, including low-density 
lipoproteins, α-synuclein and cytochrome c [59–61]. The data presented 
here demonstrate that, although modifications occur at individual Tyr 
and Trp residues in AN in a facile manner, and are formed with even 
equimolar amounts of ONOOH (i.e. single hits per protein molecule), the 
β-strand fold of AN is rather resilient towards ONOOH-mediated struc-
tural changes, with no significant perturbations in the secondary 
structure observed with micromolar levels of ONOOH. However, with 
higher doses (>100 times molar excess; low millimolar ONOOH levels), 
AN undergoes unfolding, and the thermal stability of the protein is 
decreased. Aggregated species were also detected under these condi-
tions, presumably stabilized by intermolecular interactions between 
unfolded species. However, aggregates were also observed after expo-
sure to sub-millimolar levels of ONOOH, where the secondary structure 
of AN appears to be intact, suggesting that other mechanisms are also 
involved. 
AN, which lacks the two β-strands that are present at the N-terminus 
of the full-length FNIII1 module, has a flexible structure with exposed 
hydrophobic patches similar to those detected in the precursors of am-
yloid fibrils [42,62]. These patches are likely to be involved in sFN 
formation, but may also stabilize AN aggregates through intermolecular 
beta-strands, consistent with our observation that (unmodified) AN 
forms a complex with the dye ThT, a molecule that is known to bind to 
amyloid-type aggregates. Amyloid-like aggregates have also been re-
ported to be formed from other FNIII modules, and also intact FN [63, 
64]. It was therefore relevant to investigate if these types of protein 
aggregates were also present in modified AN. However, ONOOH expo-
sure did not increase binding of ThT to AN. On the contrary, a marked 
drop in ThT fluorescence was observed after exposure to high micro-
molar levels of oxidant, suggesting that the oxidation-induced aggre-
gates are not stabilized by intermolecular beta-strands. This decreased 
Fig. 8. Binding of ThT to modified AN. AN (40 μM) was incubated with 
different concentrations of ONOOH (0.8 μM  8 mM) for 30 min, with the 
binding of ThT (25 μM) subsequently examined by fluorimetry with λex 440 nm 
(9 nm slit width) and λem 465–600 nm (15 nm slit width) using 10 μM AN in 10 
mM phosphate buffer supplemented with 20 μM CHAPS. The control spectrum 
is that of ThT in the same buffer in the absence of AN. 
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binding of ThT can also be rationalized in terms of the known properties 
of native and modified Tyr and Trp residues. Thus, the native amino acid 
side-chains are hydrophobic in nature and would be expected to asso-
ciate with ThT, whereas the products 3-nitroTyr and 6-nitroTrp are more 
polar due to the presence of the nitro function. Furthermore, it is known 
that nitration of Tyr decreases the pKa of the phenol function (Tyr-OH), 
present on the aromatic ring, from 10.5 to approximately 7.1 [65], such 
that at pH 7.4, a large proportion of the 3-nitroTyr will be present as the 
charged phenolate form (i.e. Tyr-O-). The latter would not be expected to 
bind ThT. Moreover, such species may potentially stabilize high mass 
aggregates through intermolecular interactions with positive charges on 
the side-chains of lysine and arginine. 
FN fibrils in the ECM are critical for adhesion, migration and pro-
liferation of fibroblast, endothelial and epithelial cells and are also 
important for wound repair, including within the artery wall and skin [3, 
66]. It has been proposed that native ECM assembly involves the tran-
sient unfolding of FNIII modules by mechanical forces induced through 
ECM-cell contacts between FN, integrin and actin. These FNIII modules 
promote the formation of fibrils through interactions between cryptic 
FN-FN interaction sites exposed by the strain-induced unfolding. This 
model is similar to the mechanism of sFN formation where hydrophobic 
patches in AN, which are exposed due to the absence of two beta-strands 
in the FNIII fold, are proposed to initiate fibrillation through interactions 
with transiently unfolded FNIII modules [11]. Thus, AN-promoted FN 
fibrillation can be regarded as a model of in vivo FN polymerization. 
We have shown here that the ability of AN to polymerize FN is 
impaired with moderate ONOOH exposure, as indicated by the 
decreased yield of sFN in sedimentation assays. The lag phase observed 
in the turbidity assay with high ONOOH levels suggests that the kinetics 
of sFN formation are also affected. This would suggest that oxidant 
exposure modifies sites on AN that are important for FN polymerization. 
One candidate is Tyr40, which has been previously reported to be 
crucial for AN-induced sFN polymerization [42], and which we have 
demonstrated to be nitrated on ONOOH exposure. However, possible 
roles for other Tyr and Trp residues, which were also detected as 
modified species (nitrated or as dimers), cannot be excluded, so it is not 
currently possible to correlate the loss-of-function with modification at a 
particular residue, and it is probable that alterations at multiple residues 
may contribute. Even though ONOOH impairs the ability of AN to form 
sFN, modified AN species appear to be incorporated into sFN, as 
demonstrated by the detection of AN oligomers and 3-nitroTyr species in 
sFN. Similarly, modified FN molecules appear to be incorporated into 
sFN. In contrast to AN however, ONOOH treatment of FN does not 
appear to influence sFN polymerization under the conditions tested 
here. As discussed above, the extent of modification at particular sites on 
FN are likely to be lower than at specific residues in AN, due to the large 
number of other potentially reactive residues in FN which include 
reactive Cys, cystine, and Met residues, as well as large numbers of Tyr 
and Trp side chains. 
Overall, the data presented here demonstrate that AN is readily 
modified by ONOOH with the level of structural perturbations 
increasing in a dose-dependent manner with higher oxidant concentra-
tions, both at the level of individual side chains, as well as the overall 
protein structure, with this being associated with the formation of high 
molecular mass aggregates; the later may involve both covalently and 
non-covalently bound species. Further studies are however required to 
determine the role of individual modifications (e.g. at Tyr40), to 
investigate how oxidants influence the molecular interactions between 
AN and FN, and the consequences of these processes for sFN formation. 
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